SC Filed 2022-10-04 Event — SEC 0001104659-22-105935 →

RA CAPITAL MANAGEMENT, L.P. → Solid Biosciences Inc. SLDB

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

20 13D/G filings on this issuer

19 other filings besides this one

Filer Track Record

78 filings by this filer

77 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 11.18

17,667,300 shares short · -3.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $13.63M

Point72 Asset Mgmt

Other 13D/G Filings on Solid Biosciences Inc.

Filed	Form	Filer	Stake	Shares
2026-06-24	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	12,036,126	view →
2025-02-21	SCHEDULE	BCLS SB Investco, LP	7.80%	6,179,042	view →
2025-02-21	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	9.90%	7,989,820	view →
2025-02-21	SCHEDULE	PERCEPTIVE ADVISORS LLC	15.60%	11,934,679	view →
2024-01-12	SC	BCLS SB Investco, LP	—	—	view →
2024-01-11	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2024-01-10	SC	BCLS SB Investco, LP	—	—	view →
2022-12-06	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2022-12-05	SC	BCLS SB Investco, LP	—	—	view →
2022-12-05	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-10-03	SC	BCLS SB Investco, LP	—	—	view →
2021-03-25	SC	BCLS SB Investco, LP	—	—	view →
2021-03-23	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2021-03-23	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2020-12-17	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2020-12-16	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2020-12-11	SC	BCLS SB Investco, LP	—	—	view →
2019-07-30	SC	BCLS SB Investco, LP	—	—	view →
2019-07-30	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

Filed	Form	Issuer	Stake	Shares
2026-07-23	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC.	—	18,415,956	view →
2026-07-22	SCHEDULE 13D/A	Freenome, Inc.	—	15,367,270	view →
2026-07-21	SCHEDULE 13D/A	VOR BIOPHARMA INC.	—	12,937,855	view →
2026-07-20	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-07-07	SCHEDULE 13D/A	Climb Bio, Inc. CLYM	33.00%	23,249,186	view →
2026-07-02	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	4.10%	1,985,541	view →
2026-06-26	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	6.00%	2,915,742	view →
2026-06-24	SCHEDULE 13D/A	SOLID BIOSCIENCES INC. SLDB	—	12,036,126	view →
2026-06-22	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	3,654,307	view →
2026-06-18	SCHEDULE 13D	Parabilis Medicines, Inc. PBLS	23.80%	28,933,371	view →
2026-06-15	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	36.60%	17,811,623	view →
2026-06-15	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	5,138,703	view →
2026-06-03	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-21	SCHEDULE 13G	Sana Biotechnology, Inc. SANA	—	—	view →
2026-05-14	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	6,116,140	view →
2026-05-13	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	—	16,377,468	view →
2026-01-09	SCHEDULE	Cidara Therapeutics, Inc.	—	—	view →
2025-11-07	SCHEDULE	Sionna Therapeutics, Inc. SION	22.60%	10,071,712	view →
2025-11-07	SCHEDULE	LENZ Therapeutics, Inc. LENZ	13.60%	4,265,106	view →
2025-11-03	SCHEDULE	89bio, Inc.	—	—	view →

Showing 20 of 77

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →